Monday, November 24, 2014

Epilepsy Seizures Drop 50%

Epilepsy Seizures Drop 50% in Cannabidiol Study

Lexaria Develops Proprietary Cannabidiol Technology

VANCOUVER, British Columbia, Nov. 24, 2014 (GLOBE NEWSWIRE) -- A new
study from Orrin Devinsky, MD, of the New York University School of
Medicine, suggests that Cannabidiol (CBD) may radically reduce seizures
in patients with epilepsy. Dr. Devinsky administered cannabidiol to 23 patients with
treatment-resistant epilepsy. Thirty-nine percent of the patients saw
their seizure rates drop by more than 50%. Four patients (17%) had no
seizures for the last month of treatment.

Lexaria
(CSE:LXX) (OTCQB:LXRP) has acquired 51% of PoViva Corp, an innovative
health company developing Cannabidiol (CBD)-infused products. Lexaria
may increase its ownership position to 75% at a later date. "Most CBD's taste awful," stated Lexaria CEO and Chairman Chris Bunka in an exclusive interview with Financial Press.
"Marian Washington and Michelle Reillo – the two principals at PoViva –
have developed patent-pending technology to bind CBD to a lipid. As
well as enabling the body to process the CBDs more efficiently, this
technology makes it taste much better." The first PoViva Tea by Lexaria will be a traditional black tea, which
accounts for about 85% of all the tea consumed. Initially Lexaria will
sell the CBD lipid-bound tea loosely - and then as the product line gets
traction Bunka anticipates introducing flavored teas and tea bags.

In March, 2014 Lexaria entered into the medical marijuana market in
Canada where it is legal federally. Its production license application
is being reviewed by Health Canada. "We continue to press for that license," stated Bunka. "But we made an
executive and board decision to build immediate value for the company
pursuing opportunities in the hemp-based Cannabidiol (CBD) market -
which does not require new licensing, laws or legislation." The Alternative Health sector is growing fast. A six year survey with
29,370 subjects monitored the adoption of "complementary and alternative
medicine care professionals," including "homeopathic, naturopathic, or
herbalists." The study suggests that between 16.9 million and 18.5 million Americans
are seeking an alternative health care professional at any given time.

"The US Department of Health has patented CBDs and claimed that they
are beneficial in treating Parkinson's, Alzheimer's, Cancer,
Cardio-vascular diseases and concussion," stated Bunka. "An overwhelming
body of research indicates that Cannabidiol has significant medicinal
properties." Bunka sees Cannabidiol products as much more than a niche health
market. There are many patients with Alzheimer's and other diseases who
don't want to use marijuana. Lexaria is planning to market its products to the 150 million daily tea
drinkers in the United States. The market for CBDs is much larger than
that of marijuana-users. "We're not changing focus, we're sharpening it," stated Bunka. "We are
still in the same sector, but in a 100% legal part of it, which means we
can produce foods that contain CBD and create short term cash flows for
the company."

Lexaria is in the process of launching a new e-commerce website and
setting up a national distribution center, with 1-800 call ordering. "Our marketing will include traditional media, direct marketing, and we
also are building relationships with alternative health media outlets,"
stated Bunka. "Some of these organizations have expressed interest in
affiliate marketing campaigns so we are also exploring that." Bunka has a conservative approach to alternative medicine, including
cannabis. The company has initiated a Responsible Marijuana Policy which
states that Lexaria will not sell medical marijuana containing more
than 0.3% THC to any medical marijuana patient under the age of 25. Subsequent to Lexaria's announcement, the College of Family Physicians
of Canada created new guidelines that included the recommendation that
medical marijuana in most cases would not be appropriate for patients
under the age of 25.

Lexaria is currently investigating several popular food and drink
sectors where its patent-pending lipid-binding Cannabidiol delivery
system might prove effective. Lexaria has acquired a 3-year exclusive
right to the patent-pending process to infuse CBD's into all global
markets outside of the USA.

The 2015 combined hot beverage markets of coffee and tea together,
globally, is expected to be $69 Billion according to a report by Basu
Majumder A., Bera B. and Rajan A.
According to the US Department of Health and Human Services Patent number 6,630,507, "Cannabidiol
is particularly advantageous to use because it avoids toxicity that is
encountered with psychoactive cannabinoids at high doses."
Lexaria continues to pursue the Health Canada MMPR Licensed Producer
status by way of its joint venture in Burlington Ontario with Enertopia
Corp. Meanwhile Bunka is focussed on producing cash flows from new
initiatives; including the CBD-sectors (like epilepsy treatment) derived
from already-legal hemp.

According to the Center for Disease Control and Prevention, Epilepsy
affects about 2 million people in the United States and accounts for
$15.5 billion in direct costs and indirect costs.
Lexaria is currently trading at .09 with a market capitalisation of $3.1 million.
Legal Disclaimer/Disclosure: A fee has been paid for the production and
distribution of this Report. This document is not and should not be
construed as an offer to sell or the solicitation of an offer to
purchase or subscribe for any investment. No information in this article
should be construed as individualized investment advice. A licensed
financial advisor should be consulted prior to making any investment
decision. Financial Press makes no guarantee, representation or warranty
and accepts no responsibility or liability as to its accuracy or
completeness. Expressions of opinion are those of the authors only and
are subject to change without notice. Financial Press assumes no
warranty, liability or guarantee for the current relevance, correctness
or completeness of any information provided within this article and will
not be held liable for the consequence of reliance upon any opinion or
statement contained herein or any omission. Furthermore, we assume no
liability for any direct or indirect loss or damage or, in particular,
for lost profit, which you may incur as a result of the use and
existence of the information, provided within this article.

Also, please note that republishing of this article in its entirety is permitted as long as attribution and a back link to FinancialPress.com are provided. Thank you.

EXPECT A BIG YEAR AHEAD AS WE ENTER THE SUPERBULL OF MARKET PHASES Throughout the year I evaluate where I am investing for the following 6...

THE MARKETS MOVE FAST

Follow by Email

*PLEASE READ THE CONDITIONS OF USE FOR THIS BLOG!

CONTENT POSTED ON THIS BLOG DOES NOT CONSTITUTE A BUY OR SELL RECOMMENDATION. MANY OF THE COMPANIES PROFILED HERE I AM NOT INVESTED IN AND DO NOT INTEND TO INVEST IN. THESE ARE MERELY MY THOUGHTS ON MARKET CONDITIONS AND STOCK VALUATIONS. INVESTING IN THE STOCK MARKET CAN BE VERY RISKY AND YOU SHOULD ALWAYS CONSULT AN INVESTMENT PROFESSIONAL BEFORE MAKING ANY DECISIONS. ULTIMATELY YOU ARE RESPONSIBLE FOR CONDUCTING YOUR OWN DUE DILIGENCE AND PROTECTING YOUR MONEY.

PLEASE NOTE: thetradersdigest.blogspot.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.

Release of Liability: Through use of this email / blog / website viewing or using you agree to hold thetradersdigest.blogspot.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data.Thetradersdigest.blogspot.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and thetradersdigest.blogspot.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies.

None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead thetradersdigest.blogspot.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review Sedar, SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. thetradersdigest.blogspot.com is compliant with the Can Spam Act of 2003.

Thetradersdigest.blogspot.com does not offer such advice or analysis, and thetradersdigest.blogspot.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.

Thetradersdigest.blogspot.com is often times compensated to feature certain companies. These third parties may have shares and may liquidate, which may negatively affect the stock price. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company.

The Private Securities Litigation Reform Act of 1995 provides investors a ‘safe harbor’ in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks an uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions “may”, “could”, or “might” occur. Understand there is no guarantee past performance will be indicative of future results.

In preparing this publication, thetradersdigest.blogspot.com has relied upon information supplied by its customers, and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, thetradersdigest.blogspot.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. thetradersdigest.blogspot.com is not responsible for any claims made by the companies advertised herein, nor is thetradersdigest.blogspot.com responsible for any other promotional firm, its program or its structure.

Third Party Web Sites and Information: thetradersdigest.blogspot.com and newsletter may provide hyperlinks to third party websites or access to third party content. thetradersdigest.blogspot.com does not control, endorse, or guarantee content found in such sites. You agree that thetradersdigest.blogspot.com is not responsible for any content, associated links, resources, or services associated with a third party site. You further agree that thetradersdigest.blogspot.com, Inc. shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.